here is a burgeoning focus on the relation between serum cholesterol levels and psychiatric disorders, including depression and other anxiety disorders (1,2). Information about the relation between serum lipid levels and sleep disorders is relatively limited in the psychiatric literature. In a previous study, we found that serum cholesterol level was higher in patients with recurrent panic attacks, compared with panic disorder patients without sleep panic and with healthy subjects (3). In a recent study, we also examined the relation between serum lipid concentrations in subjects with sleeprelated violent behaviours (4). Low serum cholesterol level was associated with violent behaviour during sleep.
Methods
The study subjects were 15 patients with ND (2 men and 13 women) and 15 healthy control subjects (2 men and 13 women). Subjects were aged between 18 and 65 years and had to meet the DSM-IV criteria for ND (for patients only), have good physical health as determined by physical and laboratory examination, and have no history of psychotic disorders, other sleep disorders, or current substance abuse. We interviewed all the patients with the SCID-I:CV (6) , and none of them met the criteria for other psychiatric disorders that might impact sleep and sleep architecture (for example, major depressive disorder or posttraumatic stress disorder). Two psychiatrists interviewed all patients to confirm the diagnosis of ND. To provide interrater reliability between 2 clinicians, we used the kappa statistic (kappa value was 0.77). We controlled for age in selecting our control group. The mean (SD) ages in the patient and control group were 31.5 (6.2) years and 29.6 (3.5) years, respectively. No patient was treated with antidepressants or benzodiazepines during the study. Before blood collection, there was a washout period of at least 2 weeks for psychotropic drugs.
All subjects gave informed consent to participate in this study. They were requested to avoid medication affecting lipid levels (for example, beta blockers, diuretics, androgens, estrogens, disulfiram, corticosteroids, levodopa, and aminosalycylic acid) and to abstain from a cholesterol-lowering diet for at least 2 weeks. Blood was centrifuged at 940 g for 1 minute in a refrigerated centrifuge and the serum samples were separated from blood cells. Serum cholesterol, triglyceride, and HDL-cholesterol levels were determined with commercially available kits (Roche Diagnostic GmbH, Mannheim, Germany) on a Hitachi 747 autoanalyzer (Hitachi Ltd, Tokyo, Japan). An enzymatic colorimetric method was used for cholesterol and triglyceride determination. HDL cholesterol was measured according to the direct HDLcholesterol method. LDL was calculated according to the Friedewald formula (7). We report all data as mean (SD). We used Student's t test to analyze group data. All significant levels were 2-tailed and set at the 0.02 level, and all analyses were performed with the Statistical Package for the Social Sciences (SPSS) for windows, Version 9.01 (8). Table 1 shows serum triglyceride, total cholesterol, HDL, LDL, and VLDL levels of the groups. As shown in Table 1 , t test revealed a significant difference in serum triglyceride (P = 0.007), total cholesterol (P = 0.017), and LDL (P = 0.006) levels between the groups. Patients with ND had lower serum triglyceride, lower total cholesterol, and lower LDL levels than did healthy control subjects. There was no significant between-group difference in serum HDL and VLDL levels.
Results

Discussion
In this study, we found that patients with ND had lower serum triglyceride, lower total cholesterol, and lower LDL levels than did healthy control subjects. This is the first study in the literature to examine the relation between serum lipid levels and nightmares. The underlying neurobiological mechanisms of the relation between low serum lipid concentrations and recurrent nightmares are not clear. The serotonergic system is involved in the regulation of sleep and wakefulness, its activity being maximum during wakefulness and minimum during sleep. In particular, the production of REM sleep depends on the decrease of serotonergic tone in brain stem structures (9) . Dorsal raphe nucleus neurons are most active during waking; the activity is considerably lower during slow wave sleep and lowest during REM sleep (10) . Recently, decreased dream frequency during SSRI treatment was reported (11) . This implicates serotonergic REM suppression as well. Conversely, the authors suggested an augmentation of report length and bizarreness during acute SSRI discontinuation. This augmentation may be related to cholinergic rebound from serotonergic suppression. SSRIs may induce nightmares (12), although controversial results have also been reported in the literature (13) . A recent study investigated the effect of pyridoxine (vitamin B 6 ) on dreaming in a double-blind, placebo-controlled study (14) . Vitamin B 6 was found to increase dream vividness and the ability to recall dreams. This result may suggest that vitamin B 6 , an enzyme that catalyzes the rate-limiting step in 5-HT synthesis, acts by increasing cortical arousal during periods of REM sleep. Membrane cholesterol modulates the functional properties of the 5-HT transporter by specific molecular interactions (15) . Low cholesterol may affect serotonergic neuronal activity and some types of 5-HT receptors and thus may be related to nightmares.
Some neuroactive steroids are potent modulators of an array of ligand-gated ion channels and distinct G protein-coupled receptors, and they can influence sleep and memory (16) . This ability of this class of compounds may affect both the primary excitatory and the inhibitory systems of the CNS. For example, allopregnanolone displays anxiolytic and hypnotic activities enhancing GABA-medicated chloride (17, 18) . A possible association between nightmares and lipid levels may be established through these compounds because they are synthesized de novo from cholesterol by astrocytes and oligodendrocites. Résultats : Les patients souffrant du trouble des cauchemars avaient un taux sérique de triglycérides plus faible, un cholestérol total plus faible, et des taux de LDL moins élevés que les sujets témoins.
Conclusion :
Ces résultats indiquent que les cauchemars sont associés à des taux de lipides sériques faibles.
